Role of vitamin D3 on the activity patterns of hepatic drug metabolizing enzymes in transplantable murine lymphoma

Cancer Investigation

Volumn 14, Issue 4, 1996, Pages 328-334

  Sardar, Sutapa ^a   Chatterjee, Malay ^a   Ghosh, Shanta ^b   Roy, Krishna ^c  

^a JADAVPUR UNIVERSITY   (India)

^b Radiotherapy Unit   (India)

^c NRS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; TUMOR MARKER; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; GROWTH INHIBITION; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CYTOSOL; DRUG EFFECT; ENZYMOLOGY; LIVER; LIVER MICROSOME; METABOLISM; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; CHOLECALCIFEROL; CYTOCHROME P-450 ENZYME SYSTEM; CYTOSOL; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; LIVER; LYMPHOMA; MALE; MICE; MICROSOMES, LIVER; NEOPLASM TRANSPLANTATION; TIME FACTORS;

EID: 0029666445     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609012159     Document Type: Article

References (41)

1. 3 analogs correlates with inhibition of DNA synthesis and reduced calmodulin concentration. Lab Invest 55:269-275, 1986.
2. 3 in HL-60 promyelocytic leukemia cells. J Biol Chem 262:4104-4108, 1987.
3. 3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin II and augmentation of interleukin I. Cell Immunol 98:311-322, 1986.
4. 3 is correlated to receptor occupancy. J Biol Chem 261:16943-16947, 1986.
5. Henry HL, Norman AW: Vitamin D: Metabolism and biological actions, Annu. Rev. Nutr 4:493-520, 1984.
6. Bell NH: Vitamin D - Endocrine system. J Clin Invest 76:1-6, 1985.
7. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102:937-943, 1981.
8. 3 receptors in established human cancer cell lines in culture. Cancer Res 42:1116-1119, 1982.
9. 3 and its analogs on butyrate-induced differentiation of HT-29 human colnic carcinoma cells and on the reversal of the differentiated phenotype. Arch Biochem Biophys 276:415-423, 1990.
10. 3. Cancer Res 45:5426-5430, 1985.
11. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T: 1,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60): The presence of receptors and induction and differentiation. Biochem J 204:713-719, 1982.
12. 3. Proc Natl Acad Sci USA 80:201-204, 1983.
13. Goldie H, Felix MD: Growth characteristics of free tumour cells transferred serially in the peritoneal fluid of mouse. Cancer Res 11:72-80, 1951.
14. Rana MP, Ghosh R, Chatterjee M: Changes in the tissue levels of glulathione, extent of lipid peroxidation and activity of glutathione peroxidase in transplantable murine lymphoma. Oncology 51:25-29, 1994.
15. 3-1α-hydroxylase in porcine hepatic tissue: Subcellular localization to both mitochondria and microsomes. Proc Natl Acad Sci USA 87:6009-6013, 1990.
16. Herzfeld A, Greengard O: The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 37:231-238, 1977.
17. Sardar S, Mondal A, Chatterjee M: Protective role of vanadium in the survival of hosts during the growth of a transplantable murine lymphoma and its profound effects on the rates and patterns of biotransformation. Neoplasma 40:27-30, 1993.
18. Sarkar A, Mukherjee B, Rana MP, Chatterjee M: Comparative patterns of hepatic drug metabolizing enzymes and possible correlation to chromosomal aberrations in transplantable murine lymphoma - A time course study. Cancer Invest 1994 (in press).
19. Sarkar A, Mukherjee B, Chatterjee M: Inhibitory effect of β-carotene on chronic 2-acetylaminofluorine induced hepatocarcinogenesis in rat: Reflection in hepatic drug metabolism. Carcinogenesis 15:1055-1060, 1994.
20. Guengerich FD: Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48:2946-2954, 1988.
21. Holick MF: The use and interpretation of assays for vitamin D and its metabolites. J Nutr 120:1464-1469, 1990.
22. Habig WH, Pabst MJ, Jacoby WB: Glutathione transferases: The first enzymatic step in mercapturic acid formation. J Biol Chem 251:7130-7139, 1974.
23. Isselbachor KJ, Chrabos MF, Quinn RC: The stabilization and partial purification of a glucuronyl transferase from rabbit liver microsomes. J Biol Chem 237:3033-3036, 1962.
24. Omura T, Sato R: The carbon monoxide binding pigment of liver microsomes. I. Evidence for its haemo-protein nature. J Biol Chem 239:2370-2385, 1964.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RL: Protein measurement with the phenol reagent. J Biol Chem 93:265-275, 1951.
26. Jacoby WB, Habig WH, eds: Enzymatic Basis of Detoxication, Vol. 2, New York, Academic Press, 1980, pp 63-94.
27. Mannervik KB: The isozymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 57:357-417, 1985.
28. Mannervik B, Alin P, Gluthenberg C, Jensson H, Tahir MK, Warholm M, Jomvall H: Identification of three classes of cytosolic glutathione transferase common to several mammalian species. Proc Natl Acad Sci USA 82:7202-7206, 1985.
29. Kano T, Sakai M, Muramatsu M: Structure and expression of a human class I GST mRNA. Cancer Res 47:5626-5630, 1987.
30. Benson AM, Junketer MJ, Morrow JF: Kinetics of glutathione transferase, glutathione transferase mRNA and reduced nicotinamide adenine dinucleotide (phosphate): Quinone reductase induction by 2(3)-tert-butyl-4-hydroxyanisole in mice. Cancer Res 44: 5256-5261, 1984.
31. Pearson WR, Windle JJ, Morrow JF, Benson AM, Talalay P: Increased secretion of glutathione S-transferases in response to anti-carcinogenic anti-oxidants. J Biol Chem 258:2052-2062, 1983.
32. Moorghen M, Cairns J, Forrester LM, Hayes AH, Catlan AR, Wolf CR, Harris AL: Enhanced expression of glutathione-S-transferase in cotorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 12:13-17, 1991.
33. Benson AM, Batzinger RP, Ou SYL, Bueding E, Cha YN, Paul T: Elevation of hepatic glutathione 5-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res 38:4486-4495, 1978.
34. Talalay P, Batzinger RP, Benson AM, Bueding E, Cha YN: Biochemical studies on the mechanism by which drug antioxidants suppress mutagenic activity. Adv Enzyme Regul 17:23-26, 1979.
35. 3 receptors: Gene regulation and genetic circuitry. FASEB J 2:3043-3053, 1988.
36. Gessner T: Occurrence of steroid glucyronyl transferase in a hepatoma. Cancer Res 37:2275-2281, 1977.
37. Bock KW, Lilierblum W, Pfeil H, Eriksson LC: Increased uridine diphosphate glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res 42:3747-3752, 1982.
38. 1 and benzo(a)pyrene. J Biol Chem 259:12495-12501, 1984.
39. 3-stimulated mRNAs in rat small intestine. Arch Biochem Biophys 251:403-412, 1986.
40. Ghazarian JB, Jefcoate CR, Knutson JC, Orme Jhonson WH, Deluca HF: Mitochondrial cytochrome P-450: A component of chick kidney 25-hydroxy cholecalciferol-1-α-hydroxylase. J Biol Chem 249:3026-3033, 1974.
41. 3 receptor in mouse fibroblasts. Biochem Biophys Res Commun 131:378-385, 1985.